A Dr. Martens store at Westfield Century City mall in Los Angeles, CA, USA. Add to that some disappointing sales in the U.S. in the golden quarter, a market viewed as key for long-term growth.

for 57.85p — a 9.8% discount to the prevailing market price. But if Dr Martens can sort its problems, I think it could be something of a bargain. In FY27, analysts are forecasting EPS of 7.7p.